Award
Delivery Order #SPE2DR26FN3Z2
Delivery Order for Briviact Tablets under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$2,871.18
Ceiling
$2,871.18
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FN3Z2
NAICS
424210
This award pertains to a delivery order contract issued to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company. The contract involves the procurement of Briviact 100 mg tablets, a critical pharmaceutical product, to support federal healthcare requirements. Originating as part of a larger indefinite delivery vehicle (IDV) contract previously awarded to AmerisourceBergen, this delivery order exemplifies ongoing supply commitments essential for public health operations. The contract underscores the agency's emphasis on securing vital medications through reliable and timely delivery. The scope includes the provision and distribution of specified pharmaceutical units to a designated location in Pennsylvania within a short, specified timeframe. This action continues under the framework of the existing IDV, which was non-competitively awarded to ensure consistent access to essential drug supplies. Key aspects include the maintenance of drug availability and support for federal healthcare infrastructure. The delivery order reflects a brief but critical operational window, emphasizing prompt fulfillment and operational efficiency.
Description
4570903390!BRIVIACT 100 MG TABLET 60S